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for immunization is sparse and there is uncertainty regarding
the optimal structure of incentives in terms of size, schedule,
and design.
Methods:
A 12-arm randomized controlled trial is being conducted in
Karachi, Pakistan with 10 incentive arms of varying size
(amount), schedules (progressivity) and design (certainty of
payment), an exclusive SMS arm and control arm. The
incentives are provided through two mechanisms: mobile air
time and mobile-money through a mobile-money provider.
Children were enrolled when they presented to the study sites
for either BCG, Penta-1, or Penta-2 vaccine.
Results:
A total of 11,197 children were enrolled between Nov 2017 and
Oct 2018 with approximately 800 children in each incentive
arm and 1600 and 1599 in SMS and Control arm, respectively.
As of Jan 09, 2020, Penta-3 and Measles-1 coverage are lowest
in the control arm (71% and 60% respectively) and highest in
the high-flat-lottery arm (78% and 69% respectively) with
uniformly progressing incentive amounts along the immuniza-
tion schedule.
Discussion:
Interim results suggest that small mobile-based incentives
coupled with SMS reminders can significantly improve
immunization coverage in children. The final analysis will
provide robust evidence of this impact and provide policy
implications for the most optimal incentive structure that can
build caregiver demand for effectively increasing child
immunization in an LMIC setting.
Key messages:
 Small incentives (USD<15) coupled with simple SMS
reminders can improve immunization coverage and time-
liness in low resource settings in an inexpensive, logistically
simple way.
 The study will provide experimental evidence on optimal
incentive design, structure, and size of small incentives for a
cost-effective approach to increase immunization coverage
and timeliness.
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Globally, in 2018 1.7 million people contracted Human
Immunodeficiency Virus (HIV) and 770,000 people died
from AIDS-related illnesses. Men Who Have Sex with Men
(MSM) have one of the highest probabilities of HIV
transmission.
In Italy, in 2018 2,847 new HIV cases were diagnosed, of which
39% among MSM. The MSM population accounts for 16,690
individuals whereof 50% already underwent the Highly Active
Antiretroviral Therapy (HAART). The aim of this study is to
evaluate the cost-effectiveness of daily Pre-Exposure
Prophylaxis (PrEP) in the Italian MSM susceptible population.
A Markov transition model was calibrated to the HIV
epidemic among MSM in Italy, comparing PrEP to naı̈ve
patients (NP). Model parameters were retrieved by querying
scientific databases. Transition probabilities were adjusted for
incidence of HIV while costs and benefits were discounted at
an annual rate of 3%. The impact on results of critical
parameters was explored through a Monte Carlo-based
sensitivity analysis. The cost-effectiveness analysis results
were reported as Incremental Cost-Effectiveness Ratio
(ICER) express as E per Quality Adjusted Life Year (QALY)
gained.
The introduction of such a PrEP program would result in a
total cost of E822,398,199 million and lead to a gain of 70,762
discounted QALYs over an 85-year time horizon.
Assuming a 92% efficacy of PrEP therapy, the ICER for the
PrEP program is E4,346.16/QALY gained. This value is
definitively lower than acceptability NICE threshold (£20,000).
PrEP can reduce the infection rate up to 60% in a five-year
period. The Monte Carlo simulation confirmed the robustness
of the model results.
This analysis showed PrEP to be cost-effective when used in a
susceptible population. Even if PrEP doesn’t protect from
other sex-related infectious diseases, it could prevent HIV
transmission, thus breaking down HIV-infection incidence
rate. Each country should reflect on the real possibility to
implement a robust Public Health program pondering the
adoption of PrEP.
Key messages:
 PrEP is very effective at reducing HIV infection when taken
correctly. It is the backbone in the ‘‘combination preven-
tion’’, necessary to reach the SDG of ending the AIDS
epidemic by 2030.
 This preliminary analysis suggests that the introduction of a
daily PrEP program for MSM in Italy is cost-effective and
possibly cost saving in the long term.
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HIV/AIDS is a public health problem worldwide because
undiagnosed patients maintain onward transmission. To stop
viral transmission an upscale in diagnostics is needed so that
more patients start treatment; patients on treatment and with
undetectable viral load do not transmit the virus to other
persons (‘‘Treatment as Prevention’’).
Objectives:
We aimed at identifying more HIV infections in the emergency
Department (ED) and at doing so earlier in the course of
disease.
Methods:
we designed an automated and clinician independent HIV
screening project in the ED. Electronic Medical Record (EMR)
automatically generates a request for HIV antibody (HIV Ab)
test when a patient: a) is 18-65 years of age and has a request
for any blood test; b) is not identified in the EMR as being HIV
infected; c) does not have an HIV Ab in the EMR in the
previous year. Nursing staff receive a visual warning of
patients’ eligibility for screening and an extra tube label is
printed out for HIV testing. The patient is informed of
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screening at the moment of blood drawing and an <<opt-
out >> strategy is applied (optional verbal informed consent
or <<opt-out >> of screening).
Results:
In 16 months, a total of 21.487 people were eligible for
screening. 18.072 HIV Ab screening tests were done. The opt-
out rate was 6.3% and there were 44 new HIV diagnostics
(prevalence rate 0.24%). Late presenting patients (baseline
CD4 counts <350) dropped from an average of 56% in the
previous 6 years at our institution to 36.3%. Median CD4
count at diagnostics went up from 192 to 388 cells/mm3.
Conclusions:
An automated and clinician independent HIV screening
program in the ED proved to be successful at identifying
more HIV patients and at tackling the problem of late
presentation. Diagnosing early in the course of infection is
beneficial for the individual patient, but also represents a gain
in general public health because onward transmission is
stopped by starting antiretroviral treatment.
Key messages:
 Early diagnosis through universal screening.
 Treatment as prevention.
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Recently, it became clear that undetectable equals untransmit-
table (U=U), stressing the importance of engaging in medical
care and adhering to antiretroviral therapy. HIV testing and
counselling (HTC) are offered in different settings and can be
an opportunity to inform people. We aimed to understand if
HIV testing history, including recency, place and, result, was
associated with U=U knowledge.
We used data from 2242 MSM living in Portugal participating
in EMIS 2017 that answered if they already knew that ‘‘A
person with HIV who is on effective treatment (called
’undetectable viral load’) cannot pass their virus to someone
else during sex’’, opting of 5 possible answers, dichotomized in
‘‘I already knew’’ vs. any other option. Regarding HIV testing
history, participants were categorized as follows:1. HIV
positive; 2. HIV negative and last test 12 months in a
community setting; 3. HIV negative and last test 12 months
in a medical setting, and 4. never tested for HIV or last test >12
months or tested in other settings (reference). Logistic
regression models were fitted to estimate crude and city size
and education-adjusted associations.
The median (P25; P75) age of participants was 34 (25; 43)
years. No significant statistical association was found with age
or current occupation. Those with more years of education
and living in a big or very big city were more likely to know
that U=U (aOR:1.55; 95%CI:1.20-1.99 and aOR:1.26;
95%CI:1.04-1.53, respectively). Considering HIV testing his-
tory and diagnosis, men with diagnosed HIV (aOR:6.33;
95%CI:4.50-8.90), those who had the last test in community
setting (aOR:2.44; 95%CI:1.87-3.17) and those who had the
last test in a medical setting (aOR: 1.57; 95%CI:1.26-1.95) were
more aware of U=U than those not tested in the last 12
months.
Our results suggest that there is a gradient of U=U knowledge
associated with HIV testing history among MSM. Efforts
should focus on improving counselling about U=U at all HIV
testing settings.
Key messages:
 The knowledge of U=U seems to be associated with the
place, recency and result of the last HIV test.
 Counselling should focus on the best evidence available at all
HIV testing settings, to inform and empower the
individuals.
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Background:
In the WHO European Region, in 2018, there were 16.2 newly
diagnosed HIV infections per 100,000. In Portugal, there were
9.5 new cases per 100,000 population. The aim of this study is
to analyse HIV/AIDS’s notifications in the group of primary
healthcare centres of Loures-Odivelas (ACES LO), with
340,000 inhabitants, between 2015 and 2019.
Methods:
An observational, descriptive, retrospective, quantitative study
was performed. Data was collected in March 2020, from the
National System of Epidemiological Surveillance Database.
Variables included were age, sex, HIV’s presentation, country
of probable origin of infection, probable form of transmission,
partner characteristics, pregnancy at diagnosis, reason for
testing/consultation, anti-retroviral therapy (ART) before
diagnostic of AIDS. Descriptive analysis was performed for
all variables.
Results:
In ACES LO, there were 83 notified cases of HIV infection/
AIDS between 2015 and 2019, with 36.1% of cases notified in
2019. The male to female ratio was 1.4. The average age was
41.7 years old. At time of notification, 56.6% of cases were
asymptomatic and 25.3% had clinical criteria for AIDS.
Guinea-Bissau was the probable origin of infection in 43.0%
of cases (n = 23). Men having sex with men (MSM) was the
probable form of transmission in 19.3% of cases. In 19.6% of
cases of heterosexual contact, the partner was known to have
HIV infection. Six women were pregnant at time of diagnosis.
Testing was done on a routine basis in 22.2% of cases (n = 54).
Among those with clinical criteria for AIDS (n = 21), 5 cases
had previously taken ART.
Conclusions:
There was an increase in notified cases of HIV infection/AIDS
from 2015 to 2019 in ACES LO. The male to female ratio was
lower than for Portugal in 2018.The proportion of cases with
AIDS at time of notification was higher than for Portugal in
2018. Preventive strategies should be reinforced for people
with partners diagnosed with HIV infection and perhaps for
people.
Key messages:
 More than one third of cases were notified in 2019.
 Preventive strategies should be reinforced for people with
partners diagnosed with HIV infection.
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Background:
In Ethiopia, HIV prevalence is 1.2% in 15-49-year-old women,
peaking at 3% in aged 40-44. Nationally, efforts have made to
provide HIV testing and treatment to all HIV+ subjects, and
prevention of mother-to-child transmission. This may imply a
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